Reis SC, Ferreira HIF, Tranquillini G, Tadeu VR, Franco FL, Bedin V

Idioma: Portugués
Referencias bibliográficas: 8
Paginas: 133-135
Archivo PDF: 257.71 Kb.

RESUMEN

Sin Resúmen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Happle R. Phacomatosis pigmentovascularis revisited and reclassified. Arch Dermatol. 2005; 141: 385-388.

2. Fernández MG, Boixeda P, de las Heras E, Aboin S, Millán CG, Olasolo PJ. Phakomatosis pigmentovascularis: clinical findings in 15 patients and review of the literature. J Am Acad Dermatly. 2008; 58: 88-93.

3. Seckin D, Yucelten D, Aytug A, Demirkesen C. Phacomatosis pigmentovascularis tipe IIIb. Int J Dermatol. 2007; 26: 960-963.

4. Hall BD, Cadle RG, Morrill-Cornelius SM, Bayet CA. Phakomatosis pigmentovascularis: implications for severity with especial reference to Mongolian spots associated with Sturge-Weber and Klippel-Trenaunay syndromes. Am J Med Genetics. 2007;143A: 3047-3053.

5. Landro AD, Tadini GL, Marchesi L, Cainelli T. Phakomatosis pigmentovascularis: a new case with renal angiomas and some considerations about the classification. Pediatr Dermatol. 1999; 16: 25-30.

6. Hasegawa Y, Yasuhara M. Phakomatosis pigmentovascularis type IVa. Arch Dermatol. 1985; 121: 651-655.

7. Noriega-Sanchez A, Markland ON, Herndon JH. Oculocutaneous melanosis associated with the Sturge-Weber syndrome. Neurology. 1972; 22: 256-262.

8. HuangCY, Lee PY. Phakomatosis pigmentovascularis IIb with renal anomaly. Clin Exp Dermatol. 2000; 25: 51-54.